Structured evidence table for L-Tyrosine Mood Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Tyrosine Mood Randomized Trial | Conclusion Our findings suggest that an 8-week supplementation with Portulaca oleracea can help alleviate depression and stress symptoms in patients with NAFLD. | 2 | Milkarizi N (2026) | Effects of Hydro-Ethanolic Extract of <i>Portulaca oleracea</i> (Purslane) on Depression, Anxiety, and Stress Symptoms in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blind Controlled Trial. |
| L-Tyrosine Mood Randomized Trial | Introduction Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver condition globally. | 2 | Milkarizi N (2026) | Effects of Hydro-Ethanolic Extract of <i>Portulaca oleracea</i> (Purslane) on Depression, Anxiety, and Stress Symptoms in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blind Controlled Trial. |
| L-Tyrosine Mood Randomized Trial | Preliminary hypotheses suggest that Portulaca oleracea extract may improve mental health by modulating stress-related hormones. | 2 | Milkarizi N (2026) | Effects of Hydro-Ethanolic Extract of <i>Portulaca oleracea</i> (Purslane) on Depression, Anxiety, and Stress Symptoms in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blind Controlled Trial. |
| L-Tyrosine Mood Randomized Trial | Increasing evidence suggests that no single biomarker is likely to capture this complexity, and that integrative multi-omics approaches may provide a more clinically meaningful framework for precision psychiatry. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| L-Tyrosine Mood Randomized Trial | The co-occurrence of these conditions increases symptom severity, the risk of relapse, and reduces the likelihood of full remission. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| L-Tyrosine Mood Randomized Trial | This phenomenon is associated with an increased risk of hospitalization, suicide, and a marked rise in healthcare costs. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| L-Tyrosine Mood Randomized Trial | 1 2 Recurrent major depressive disorder and depressive episode (MDD; ICD-10: F32–F33) as well as generalized anxiety disorder (GAD; ICD-10: F41.1) are among the most prevalent and most burdensome psychiatric entities on a global scale. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
Source documents